{
  "id": 12280095,
  "name": "COMMONWEALTH of Pennsylvania, Appellant v. TAP PHARMACEUTICAL PRODUCTS, INC.; Abbott Laboratories; Astrazeneca PLC; Astrazeneca, Holdings, Inc.; Astrazeneca Pharmaceuticals LP; Astrazeneca LP; Bayer AG; Bayer Corporation; SmithKline Beecham Corporation d/b/a GlaxoSmithKline; Pfizer, Inc.; Pharmacia Corporation; Johnson & Johnson; Alza Corporation; Centrocor, Inc.; Ethicon, Inc.; Janssen Pharmaceutical Products, L.P.; McNeil-PPC, Inc.; Ortho Biotech, Inc.; Ortho Biotech Products; L.P.; Ortho-McNeil Pharmaceutical, Inc.; Amgen, Inc.; Immunex Corporation; Bristol-Myers Squibb Company; Baxter International Inc.; Baxter Healthcare Corporation; Immuno-U.S., Inc.; Aventis Pharmaceuticals, Inc.; Aventis Behring, L.L.C.; Hoechst Marion Roussel, Inc., Boehringer Ingelheim Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; Ben Venue Laboratories; Bedford Laboratories; Roxane Laboratories; Schering-Plough Corporation; Warrick Pharmaceuticals Corporation; Schering Sales Corporation; Dey, Inc., Appellees. Donna A. Boswell, Esq., Ann M. Vickery, Esq., and Joseph A. Young, Esq., Intervenors. Cross Appeal of Bristol-Myers Squibb Company (@ 21 MAP 2015)",
  "name_abbreviation": "Commonwealth v. TAP Pharmaceutical Products, Inc.",
  "decision_date": "2015-12-21",
  "docket_number": "No. 212 MD 2014; Nos. 14 & 21 MAP 2015",
  "first_page": "33",
  "last_page": "33",
  "citations": [
    {
      "type": "official",
      "cite": "634 Pa. 33"
    },
    {
      "type": "parallel",
      "cite": "128 A.3d 1201"
    }
  ],
  "court": {
    "name_abbreviation": "Pa.",
    "id": 8832,
    "name": "Supreme Court of Pennsylvania"
  },
  "jurisdiction": {
    "id": 6,
    "name_long": "Pennsylvania",
    "name": "Pa."
  },
  "cites_to": [],
  "analysis": {
    "cardinality": 104,
    "char_count": 1396,
    "ocr_confidence": 0.652,
    "sha256": "10c5222fd0e0b1a8bae3e11c49d474e34ba477faad15608024bdbad2f89f5e29",
    "simhash": "1:64d9ea6b534a1950",
    "word_count": 171
  },
  "last_updated": "2023-07-14T15:35:14.432984+00:00",
  "provenance": {
    "date_added": "2018-10-23",
    "source": "Harvard",
    "batch": "2018"
  },
  "casebody": {
    "judges": [
      "Justice STEVENS did not participate in the decision of this case."
    ],
    "parties": [
      "COMMONWEALTH of Pennsylvania, Appellant v. TAP PHARMACEUTICAL PRODUCTS, INC.; Abbott Laboratories; Astrazeneca PLC; Astrazeneca, Holdings, Inc.; Astrazeneca Pharmaceuticals LP; Astrazeneca LP; Bayer AG; Bayer Corporation; SmithKline Beecham Corporation d/b/a GlaxoSmithKline; Pfizer, Inc.; Pharmacia Corporation; Johnson & Johnson; Alza Corporation; Centrocor, Inc.; Ethicon, Inc.; Janssen Pharmaceutical Products, L.P.; McNeil-PPC, Inc.; Ortho Biotech, Inc.; Ortho Biotech Products; L.P.; Ortho-McNeil Pharmaceutical, Inc.; Amgen, Inc.; Immunex Corporation; Bristol-Myers Squibb Company; Baxter International Inc.; Baxter Healthcare Corporation; Immuno-U.S., Inc.; Aventis Pharmaceuticals, Inc.; Aventis Behring, L.L.C.; Hoechst Marion Roussel, Inc., Boehringer Ingelheim Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; Ben Venue Laboratories; Bedford Laboratories; Roxane Laboratories; Schering-Plough Corporation; Warrick Pharmaceuticals Corporation; Schering Sales Corporation; Dey, Inc., Appellees. Donna A. Boswell, Esq., Ann M. Vickery, Esq., and Joseph A. Young, Esq., Intervenors. Cross Appeal of Bristol-Myers Squibb Company (@ 21 MAP 2015)."
    ],
    "opinions": [
      {
        "text": "ORDER\nPER CURIAM.\nAND NOW, this 21st day of December, 2015, the Order of the Commonwealth Court is AFFIRMED.\nJustice STEVENS did not participate in the decision of this case.",
        "type": "majority",
        "author": "PER CURIAM."
      }
    ],
    "attorneys": [],
    "corrections": "",
    "head_matter": "128 A.3d 1201\nCOMMONWEALTH of Pennsylvania, Appellant v. TAP PHARMACEUTICAL PRODUCTS, INC.; Abbott Laboratories; Astrazeneca PLC; Astrazeneca, Holdings, Inc.; Astrazeneca Pharmaceuticals LP; Astrazeneca LP; Bayer AG; Bayer Corporation; SmithKline Beecham Corporation d/b/a GlaxoSmithKline; Pfizer, Inc.; Pharmacia Corporation; Johnson & Johnson; Alza Corporation; Centrocor, Inc.; Ethicon, Inc.; Janssen Pharmaceutical Products, L.P.; McNeil-PPC, Inc.; Ortho Biotech, Inc.; Ortho Biotech Products; L.P.; Ortho-McNeil Pharmaceutical, Inc.; Amgen, Inc.; Immunex Corporation; Bristol-Myers Squibb Company; Baxter International Inc.; Baxter Healthcare Corporation; Immuno-U.S., Inc.; Aventis Pharmaceuticals, Inc.; Aventis Behring, L.L.C.; Hoechst Marion Roussel, Inc., Boehringer Ingelheim Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; Ben Venue Laboratories; Bedford Laboratories; Roxane Laboratories; Schering-Plough Corporation; Warrick Pharmaceuticals Corporation; Schering Sales Corporation; Dey, Inc., Appellees. Donna A. Boswell, Esq., Ann M. Vickery, Esq., and Joseph A. Young, Esq., Intervenors. Cross Appeal of Bristol-Myers Squibb Company (@ 21 MAP 2015).\nSupreme Court of Pennsylvania.\nDec. 21, 2015."
  },
  "file_name": "0033-01",
  "first_page_order": 77,
  "last_page_order": 77
}
